Sun Pharmaceutical Industries reported a 36% drop in consolidated net profit to Rs 1,988.53 crore for the September 2026 quarter, dragged by one-time exceptional charges of Rs 1,269 crore, primarily a US…
Industry leaders from Sun Pharma, Biocon and Glenmark called on India to move beyond generic medicines and invest in innovative drug development, speaking at the Indian Foundation for Quality Management's Third Annual…
Sun Pharmaceutical Industries has signed an exclusive licensing agreement with LIB Therapeutics to commercialise and manufacture lerodalcibep, a drug for lowering LDL or bad cholesterol, in markets outside the US and China.…
Market expert Vaishali Parekh of Prabhudas Lilladher has advised caution on Biocon, stating that the stock's momentum has fizzled out previously whenever it was discussed. She said in an interview with Business…
India's drug quality watchdog, the Indian Pharmacopoeia Commission, is drafting a legally binding monograph for semaglutide, the key ingredient in blockbuster diabetes and weight-loss drugs such as Ozempic and Wegovy. The move…
Sun Pharmaceutical Industries has secured a favourable verdict in the United States antitrust litigation related to a 2008 patent settlement agreement with Pfizer over generic Lipitor (Atorvastatin). The United States Court of…
State Bank of India has five to six merger and acquisition financing deals in its pipeline, having already closed four to five deals this year including a large one, a senior official…
Sun Pharma has recalled several eye drop products in India after contamination concerns were identified during manufacturing. The company has asked distributors to stop supplying the affected medicines and return stock. Products…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.